MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 154 filers reported holding MERSANA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,337 | -61.4% | 23,100 | 0.0% | 0.00% | -75.0% |
| Q2 2023 | $75,999 | -20.0% | 23,100 | 0.0% | 0.00% | -20.0% |
| Q1 2023 | $94,941 | -29.9% | 23,100 | 0.0% | 0.01% | -37.5% |
| Q4 2022 | $135,366 | -13.2% | 23,100 | 0.0% | 0.01% | -20.0% |
| Q3 2022 | $156,000 | +45.8% | 23,100 | 0.0% | 0.01% | +66.7% |
| Q2 2022 | $107,000 | +16.3% | 23,100 | 0.0% | 0.01% | +20.0% |
| Q1 2022 | $92,000 | -36.1% | 23,100 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $144,000 | -33.9% | 23,100 | 0.0% | 0.01% | -50.0% |
| Q3 2021 | $218,000 | -30.6% | 23,100 | 0.0% | 0.01% | -37.5% |
| Q2 2021 | $314,000 | -16.0% | 23,100 | 0.0% | 0.02% | -5.9% |
| Q1 2021 | $374,000 | -46.2% | 23,100 | -11.6% | 0.02% | -45.2% |
| Q4 2020 | $695,000 | +221.8% | 26,128 | +125.5% | 0.03% | +158.3% |
| Q3 2020 | $216,000 | – | 11,589 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
| VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
| Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
| EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
| Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
| 5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
| COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
| Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |